EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy

Pasquale Pagliaro iD, C Penna iD, S Femminò iD, F G P Welt iD

Basic Research in Cardiology · 13.03.2026 · 121 (3) · 321-350

DOI: 10.1007/s00395-026-01167-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic Research in Cardiology, online erschienen am 13.03.2026. Verfasst von Pasquale Pagliaro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, University of Torino, Turin, Italy. pasquale.pagliaro@unito.it. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Precision Medicine, Cardiotonic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca, Università degli Studi di Torino.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite extensive preclinical research identifying molecular targets and cardioprotective strategies, translation into effective clinical therapies remains challenging. Cardioprotection aims to mitigate ischemia/reperfusion injury (IRI) by modulating molecular pathways, such as the Reperfusion Injury Salvage Kinase (RISK) and Survivor Activating Factor Enhancement (SAFE) pathways, as well as autophagy, inflammation, and regulated cell death, to preserve myocardial function. However, a major limitation lies in the robustness of preclinical evidence. Many experimental studies rely on simplified models that fail to reproduce the complexity of human cardiac pathophysiology, resulting in inconsistent and poorly reproducible cardioprotective effects. It is likely that RISK-SAFE pathways represent an oversimplified framework. Moreover, most experimental approaches are cardiomyocyte-centered, overlooking the critical role of the vessels in IRI. Clinical translation is further compromised by patient-related factors, including comorbidities (e.g., diabetes, hypertension), concomitant medications, and heterogeneity in reperfusion protocols, all of which attenuate cardioprotective efficacy. Additional variables, such as timing of intervention and species differences, further contribute to translational failure. Emerging approaches include pharmacological therapies (e.g., SGLT2 inhibitors, PARP inhibitors, necroptosis and ferroptosis blockers, NLRP3-targeting compounds), cell- and organelle-based strategies (e.g., mitochondrial transplantation, extracellular vesicles, non-coding RNAs), and mechanical/device-based interventions (e.g., left ventricular unloading, ischemic conditioning, controlled reperfusion, selective intracoronary hypothermia). Future research should emphasize multi-target interventions, optimized timing and delivery, and advanced tools, such as nanocarriers, gene therapy, computational modeling, and adaptive clinical trials. Strengthening the robustness of preclinical models, including human ex vivo cardiac systems, remains essential to bridge the translational gap and improve the clinical success of cardioprotective therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryPrecision MedicineCardiotonic AgentsHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

CardioprotectionCardioprotective pathwaysEmerging targetsIschemia/reperfusion injury

Substanzen

Cardiotonic Agents

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, University of Torino, Turin, Italy. pasquale.pagliaro@unito.it.
  • Department of Clinical and Biological Sciences, University of Torino, Turin, Italy.
  • Division of Cardiovascular Medicine, Department of Medicine, University of Utah Hospital, Salt Lake City, UT, USA.

ORCID-Profile: Pasquale Pagliaro, C Penna, S Femminò, F G P Welt

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Università degli Studi di Torino

Zitieren

APA

Pagliaro, P., Penna, C., Femminò, S., & Welt, F. G. P. (2026). Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy. Basic Research in Cardiology, 121(3), 321-350. https://doi.org/10.1007/s00395-026-01167-8

Vancouver

Pagliaro P, Penna C, Femminò S, Welt FGP. Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy. Basic Research in Cardiology. 2026;121(3):321-350. doi:10.1007/s00395-026-01167-8

BibTeX
@article{Pagliaro2026,
  author = {Pagliaro, Pasquale and Penna, C and Femminò, S and Welt, F G P},
  title = {Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy},
  journal = {Basic Research in Cardiology},
  year = {2026},
  volume = {121},
  number = {3},
  pages = {321--350},
  doi = {10.1007/s00395-026-01167-8}
}
Kostenlos starten →